{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06003036",
            "orgStudyIdInfo": {
                "id": "STUDY23050056"
            },
            "secondaryIdInfos": [
                {
                    "id": "R21MH134128",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R21MH134128"
                }
            ],
            "organization": {
                "fullName": "University of Pittsburgh",
                "class": "OTHER"
            },
            "briefTitle": "Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine",
            "officialTitle": "Accelerated Neuromodulation of Prefrontal Circuitry During Clozapine Treatment",
            "therapeuticArea": [
                "Mental Health",
                "Other"
            ],
            "study": "accelerated-transcranial-magnetic-stimulation-for-people-with-schizophrenia-treated-with-clozapine"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-08-08",
            "studyFirstSubmitQcDate": "2023-08-14",
            "studyFirstPostDateStruct": {
                "date": "2023-08-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-28",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Deepak Sarpal",
                "investigatorTitle": "Assistant Professor",
                "investigatorAffiliation": "University of Pittsburgh"
            },
            "leadSponsor": {
                "name": "Deepak Sarpal",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute of Mental Health (NIMH)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "In this study, the investigators will examine whether a type of repetitive transcranial magnetic stimulation called accelerated intermittent theta burst stimulation (iTBS) can augment neurocognition in individuals who receive treatment with clozapine. Following a baseline evaluation and magnetic resonance imaging (MRI), participants will undergo a session of iTBS +MRI and session of sham delivery + MRI. The order for these sessions will be blinded and randomized. The investigators predict that accelerated iTBS will enhance neurocognition relative to sham delivery."
        },
        "conditionsModule": {
            "conditions": [
                "Schizophrenia",
                "Schizoaffective Disorder"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "iTBS, then Sham",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Device: sham stimulation",
                        "Device: transcranial magnetic stimulation"
                    ]
                },
                {
                    "label": "Sham, then iTBS",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Device: sham stimulation",
                        "Device: transcranial magnetic stimulation"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "sham stimulation",
                    "description": "sham delivery of transcranial magnetic stimulation",
                    "armGroupLabels": [
                        "Sham, then iTBS",
                        "iTBS, then Sham"
                    ]
                },
                {
                    "type": "DEVICE",
                    "name": "transcranial magnetic stimulation",
                    "description": "accelerated intermittent theta burst stimulation",
                    "armGroupLabels": [
                        "Sham, then iTBS",
                        "iTBS, then Sham"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "change in brain functional connectivity within the prefrontal cortex",
                    "description": "Examine changes in left dorsolateral prefrontal cortex-basal forebrain functional connectivity following adjunctive accelerated intermittent theta burst stimulation (iTBS)",
                    "timeFrame": "1 hour"
                },
                {
                    "measure": "change in activation of the working memory network",
                    "description": "Examine whether accelerated intermittent theta burst stimulation (iTBS) is associated with functional magnetic resonance imaging (fMRI)-based changes in activation of the working memory network during AX-continuous performance task engagement",
                    "timeFrame": "1 hour"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "explore change in functional magnetic resonance imaging (fMRI) measures versus plasma n-desmethylclozapine/clozapine ratios",
                    "description": "In exploratory analyses we will compare change in dorsolateral prefrontal cortex-basal forebrain functional connectivity and change in working memory network activation in relation to plasma n-desmethylclozapine/clozapine ratios.",
                    "timeFrame": "1 month"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. A current Diagnostic and Statistical Manual of Mental Disorders 5 (DSM 5)-defined diagnosis of schizophrenia or schizoaffective disorder\n2. age 18-50 years\n3. at least 4 months of clozapine treatment\n4. history of at least 2 failed antipsychotic trials\n5. competency and willingness to sign informed consent\n6. A clinically optimized dosage of clozapine, unchanged for at least 1 month, with a minimum of 150 mg/day\n\nExclusion Criteria:\n\n1. Serious neurologic or medical condition/treatment that impacts the brain\n2. a significant risk of suicidal or homicidal behavior\n3. cognitive or language limitations, or any other factor that would preclude subjects providing informed consent\n4. pregnancy or postpartum (\\<6 weeks after delivery or miscarriage)\n5. history of treatment with electroconvulsive therapy\n6. contraindications for magnetic resonance imaging (e.g., a pacemaker)\n7. Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders 5 (DSM 5)-verified moderate or severe substance use disorder, including alcohol use disorder\n8. seizure disorder or prior history of seizures on clozapine\n9. patients taking both bupropion and clozapine\n10. prior issues with intermittent theta burst stimulation/transcranial magnetic stimulation administration\n\nConcomitant treatment with serotonin and norepinephrine reuptake inhibitors will be examined on a case-by-case basis.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "50 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Tori Blazinski",
                    "role": "CONTACT",
                    "phone": "412-246-5618",
                    "email": "blazinskit2@upmc.edu"
                },
                {
                    "name": "Deepak Sarpal",
                    "role": "CONTACT",
                    "email": "sarpaldk@upmc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Deepak K Sarpal, M.D.",
                    "affiliation": "University of Pittsburgh",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "UPMC Western Psychiatric Hospital/University of Pittsburgh",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15213",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tori Blazinski",
                            "role": "CONTACT",
                            "email": "blazinskit2@upmc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "de-identified individual participant data to the National Institute of Mental Health (NIMH) data archive"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000012559",
                    "term": "Schizophrenia"
                },
                {
                    "id": "D000011618",
                    "term": "Psychotic Disorders"
                }
            ],
            "ancestors": [
                {
                    "id": "D000019967",
                    "term": "Schizophrenia Spectrum and Other Psychotic Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M15376",
                    "name": "Schizophrenia",
                    "asFound": "Schizophrenia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "asFound": "Schizoaffective Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21838",
                    "name": "Schizophrenia Spectrum and Other Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M6254",
                    "name": "Clozapine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}